← Back to news

Markets

Is Duos Technologies Group (DUOT) a Mispriced Opportunity?

Y

SpaceX Stock Is Up. Here Are 4 Reasons I'm Still Not Buying.

Y

AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion

Y

Tech stocks live: Tech stocks mixed ahead of Micron earnings Wednesday

Y

Tech stocks live: Google and other tech stocks extend losses as AI worries creep back in

Y

Kalshi reportedly in discussions with investment banks about IPO

Y

KPMG Australia faces scrutiny over misuse of Optus information – report

Y

Canada food retail prices continue to outpace inflation

Y

Are Your Retirement Savings Safe? Inside Insurance Ratings & the Annuity Boom

Y

A US soldier was arrested for betting with classified intel — now regulators want to crack down on prediction markets

Y

TurboTax-Maker Intuit Leads 3 Cheap Tech Stocks That Pay You to Wait on the AI Boom

Y

Profound Medical Corp. (PROF) Dropped Despite High Potential

Y

Foodics acquires Greece-based hospitality business Norma AI

Y

Super Micro Jumps 11%, Dell Rises 5% as New NVIDIA Vera Rubin Systems Fuel the AI Server Trade

Y

‘I became invisible when I turned 60’: The hidden crisis of late-career unemployment

Y

As Crude Oil Prices Fall, Make This 1 Bullish Trade Instead

Y

Lucid Motors layoffs: new CEO cuts 18% of workforce

Y

SpaceX Merger Would Hurt Tesla Stock, Jefferies Says. Cathie Wood Adds Tesla.

Y

Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics

Y

Astera Labs’ (ALAB) Growth Rate Weakens Despite Earnings Growth

Y

Bitcoin Price Could Fall to $23,000 in 2026 if Stock Market Crashes Over 50% — Is It Likely?

Y

Uber board sued over alleged 'serial' compliance failures, sexual abuse lawsuits

Y

Massive Wave of Selling Is Coming, Says JPMorgan. Here’s Why It Probably Won’t Matter

Y

Is XRP (Ripple) Expected to Skyrocket?

Y

SpaceX stock tumbles 16.4%, shaving off most IPO gains since debut

Y

SpaceX stock down again, shaving off some IPO gains; confirms debt offering

Y

BeOne Medicines (ONC): Citizens Sees an Inflection Point in Its Cancer Pipeline

Y

Alnylam (ALNY) Expands Its RNAi Therapeutics Reach Into Four More Nordic Countries

Y

Can Rhythm Pharmaceuticals (RYTM) ’s New Data Help Patients With a Rare Hunger Disorder?

Y

Truist Cuts Boston Scientific (BSX) ’s Target as Doctors Change How They Use Its Heart Device

Y

Insulet (PODD): New Data Shows Its Next-Gen System Delivers Far More Automated Insulin

Y

Is Cogent Biosciences (COGT) ’s New Cancer Drug 100 Times More Precise Than What’s Already on the Market?

Y

Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise?

Y

Vaxcyte (PCVX) Doses Its First Patient in a Trial for a Disease With No Existing Vaccine

Y

Summit Therapeutics (SMMT): A $500 Million Stock Offering Pulled Just One Day After Filing

Y

Super Micro Computer (SMCI) A Data Center Stock Cheaper Than the S&P

Y

Dell Technologies (DELL) Has Gained More Than 30% Over the Past Month, Valuation Remains Cheaper Than The S&P

Y

Wells Fargo Remains a Buy on Constellation Energy (CEG)

Y

Mizuho Maintains Outperform Rating on Oracle Corporation (ORCL)

Y

Wall Street Sees More Than 40% Upside for Meta Platforms (META)

Y

OpenAI in Talks to Lease 10 GW Data Center in Ohio, Nvidia (NVDA) To Play an Important Role – Reuters

Y

Microsoft (MSFT) Faces Shareholder Lawsuit; TD Cowen Maintains Buy Rating

Y

Stocks Supported by Strength in Chipmakers and AI-Infrastructure Stocks

Y

Jefferies Financial Group (JEF): One of the Premier Financial Stocks to Buy According to Warren Buffett

Y

Fiserv Stock: Is FISV Underperforming the Financial Sector?

Y

Ally Financial Inc. (ALLY): One of the Best Financial Stocks to Buy According to Berkshire Hathaway

Y

Moody’s Corporation (MCO): One of the Best Financial Stocks According to Warren Buffett

Y

CRH Buys Arcosa for $8.5 Billion in Energy Transmission Expansion

Y

Is SpaceX Stock a Buy at a $2.5 Trillion Valuation?

Y

Most investors oppose semiannual reporting option: CFA Institute

Y